» Articles » PMID: 22829233

The Relationship Between Cardiac and Liver Iron Evaluated by MR Imaging in Haematological Malignancies and Chronic Liver Disease

Overview
Journal Blood Cancer J
Date 2012 Jul 26
PMID 22829233
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Although iron overload is clinically significant, only limited data have been published on iron overload in haematological diseases. We investigated cardiac and liver iron accumulation by magnetic resonance imaging (MRI) in a cohort of 87 subjects who did not receive chelation, including 59 haematological patients. M-HIC (MRI-based hepatic iron concentration, normal values <36 μmol/g) is a non-invasive, liver biopsy-calibrated method to analyse iron concentration. This method, calibrated to R2 (transverse relaxation rate), was used as a reference standard (M-HIC(R2)). Transfusions and ferritin were evaluated. Mean M-HIC(R2) and cardiac R(*) of all patients were 142 μmol/g (95% CI, 114-170) and 36.4 1/s (95% CI, 34.2-38.5), respectively. M-HIC(R2) was higher in haematological patients than in patients with chronic liver disease or normal controls (P<0.001). Clearly elevated cardiac R2(*) was found in two myelodysplastic syndrome (MDS) patients with severe liver iron overload. A poor correlation was found between liver and cardiac iron (n=82, r=0.322, P=0.003), in contrast to a stronger correlation in MDS (n=7, r=0.905, P=0.005). In addition to transfusions, MDS seemed to be an independent factor in iron accumulation. In conclusion, the risk for cardiac iron overload in haematological diseases other than MDS is very low, despite the frequently found liver iron overload.

Citing Articles

MRI for Quantification of Liver and Cardiac Iron in Thalassemia Major Patients: Pilot Study in Indian Population.

Mandal S, Sodhi K, Bansal D, Sinha A, Bhatia A, Trehan A Indian J Pediatr. 2017; 84(4):276-282.

PMID: 28233255 DOI: 10.1007/s12098-017-2310-8.


Safety and efficacy of deferasirox in the management of transfusion-dependent patients with myelodysplastic syndrome and aplastic anaemia: a perspective review.

Adams R, Bird R Ther Adv Hematol. 2013; 4(2):93-102.

PMID: 23610617 PMC: 3629757. DOI: 10.1177/2040620712472355.

References
1.
Cazzola M, Della Porta M, Malcovati L . Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program. 2008; :166-75. DOI: 10.1182/asheducation-2008.1.166. View

2.
Olthof A, Sijens P, Kreeftenberg H, Kappert P, Irwan R, van der Jagt E . Correlation between serum ferritin levels and liver iron concentration determined by MR imaging: impact of hematologic disease and inflammation. Magn Reson Imaging. 2007; 25(2):228-31. DOI: 10.1016/j.mri.2006.09.019. View

3.
Wood J, Aguilar M, Otto-Duessel M, Nick H, Nelson M, Moats R . Influence of iron chelation on R1 and R2 calibration curves in gerbil liver and heart. Magn Reson Med. 2008; 60(1):82-9. PMC: 2525452. DOI: 10.1002/mrm.21660. View

4.
Westwood M, Firmin D, Gildo M, Renzo G, Stathis G, Markissia K . Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging. 2005; 21(5):531-8. DOI: 10.1007/s10554-005-0651-2. View

5.
Jensen P, Jensen F, Christensen T, Eiskjaer H, Baandrup U, Nielsen J . Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood. 2003; 101(11):4632-9. DOI: 10.1182/blood-2002-09-2754. View